We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Rule Prevents Blocking Petitions on ANDAs, 505(b)(2) Applications
Rule Prevents Blocking Petitions on ANDAs, 505(b)(2) Applications
January 6, 2012
Under a new proposed rule, FDA decisions on ANDAs or 505(b)(2) applications would not be delayed by pending citizen petitions, or petitions for stay of action, unless a delay is necessary to protect public health.